The 2022 Society for Biomaterials, Technology Innovation and Development Award goes to Dr. Guillermo Ameer and the Acuitive Technologies Team

BALTIMORE, MD., May 2022

It all started with a vision by Northwestern's Dr. Guillermo A. Ameer, Daniel Hale Williams Professor of Biomedical Engineering at the McCormick School of Engineering and Surgery at the Feinberg School of Medicine, who has been awarded the 2022 Technology Innovation and Development Award by the Society for Biomaterials. This award recognizes an individual or team's successful application of basic and applied biomaterials research in the development of a novel medical product or technology that significantly benefits the health and well-being of patients.

Biomaterial Technology Moves from Lab Bench to the Orthopedic Market

EVANSTON, IL., December 2021

Northwestern biomedical engineer Guillermo A. Ameer has achieved a rare, major accomplishment: A medical product based on novel biomaterials pioneered in his laboratory will be widely available for use in musculoskeletal surgeries to directly benefit patients. The biomaterial technology, called CITREGEN, developed by the startup company Acuitive Technologies Inc., is featured in Stryker Corporation’s CITRELOCK, an innovative device that debuted in September. 

Acuitive Technologies Enters Sport Medicine Market - CITRESPLINE™& CITRELOCK™

Acuitive Technologies Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRESPLINE™ and CITRELOCK™ Ligament Reconstruction Devices using their patented CITREGEN™ biomaterial technology, a market disruptive bioresorbable synthetic polymer. 

Acuitive Technologies Granted FDA 510(k) Clearance for CITREFIX™ Knotless Suture Anchor

Acuitive Technologies today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITREFIX™ Knotless Suture Anchor System with CITREGEN™ material technology, a new generation bioresorbable synthetic polymer.

Acuitive Technologies Granted FDA 510(k) Clearance for CITREGEN™ CITRELOCK™ Tendon Interference Screw System

Acuitive Technologies today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRELOCK™ Interference Screw System with CITREGEN™ material technology, a new generation thermoset bioresorbable synthetic polymer now FDA cleared.